Cell and Gene Therapy Catapult Seminar Day @ the University of Edinburgh

Actions Panel

Cell and Gene Therapy Catapult Seminar Day @ the University of Edinburgh

By Cell and Gene Therapy Catapult and The University of Edinburgh / MRC Centre for Regenerative Medicine

Date and time

Mon, 18 Mar 2019 09:00 - 16:30 GMT

Location

Chancellor's Building

49 Little France Crescent Edinburgh EH16 4SB United Kingdom

Description

The Cell and Gene Therapy (CGT) Catapult and The University of Edinburgh MRC Centre for Regenerative Medicine invite you to take part in a one-day seminar event for biomedical researchers on Monday 18th March, 09:00-16:30 at the Chancellor’s Building, 49 Little France Crescent, Edinburgh, beside the Royal Infirmary of Edinburgh.

The day comprises a series of morning talks covering key considerations for translation and commercialisation of cell and gene therapy research, understanding how to ensure commercial success for your advanced therapy projects.

Talks will be followed by afternoon 1:1 clinics with CGT Catapult’s own experts spanning how to address current and future pre-clinical and clinical ATMP development needs, regulatory and reimbursement challenges, and addressing barriers to scale-up manufacturing. The full programme is listed below.

Please indicate if you would like to receive tailored feedback on a project idea during the registration process by giving a brief summary of your project and any questions you would like to discuss with our experts.

We hope you will be able to join us.

Spaces are limited so please RSVP by registering for free above.

  • 09.00-09.30, Breakfast and registration
  • 09.30-10.00, Welcome and introduction to the Cell and Gene Therapy Catapult, Dr Jacqueline Barry, Chief Clinical Officer
  • 10.00-10.30, Understanding your pre-clinical data package needs, Dr Julie Tordo, Senior Non-Clinical Study Manager
  • 10.30-11.00, Protecting inventions and understanding freedom to operate, Dr Jodie Albutt, Head of Intellectual Property
  • 11.00-11.30, Coffee break
  • 11.30-12.00, Process scaling and manufacturing, Dr Jonathan Appleby, Chief Scientific Officer
  • 12.00-12.30, Regulatory considerations for clinical translation of ATMPs, Dr Patrick Ginty, Head of Regulatory Affairs
  • 12.30-13.00, The importance of planning for ATMP reimbursement early, Jesper Jorgensen, Health Economics and Market Access Manager
  • 13.00-13.15, MATCH project: a case study, Professor John Campbell, Associate Director of Research and Development, Scottish National Blood Transfusion Service
  • 13.15-14.00, Lunch and networking
  • 14.00-16.30, 1:1 advisory and feedback clinics

Organised by

The University of Edinburgh is one of the world’s top universities. Established in 1583, it is Scotland’s largest University, ranked number 1 in Scotland and 4th in the UK for research power, based on research quality and breadth and 21st in the 2015/16 QS World University rankings. Edinburgh is a research-intensive university and won £305 million in competitive research grants in 2014/15. 

The MRC Centre for Regenerative Medicine (CRM, www.crm.ed.ac.uk) was established in 2008. It is part of the University of Edinburgh Institute for Regeneration and Repair. CRM scientists and clinicians study stem cells, disease and tissue repair to advance human health. 

Sales Ended